Post-Interleukin 17
(Unterschied zwischen Versionen)
| Zeile 1: | Zeile 1: | ||
{{tp|p=32353597|t=ä. SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy |pdf=|usr=}} | {{tp|p=32353597|t=ä. SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy |pdf=|usr=}} | ||
{{tp|p=32358580|t=ä. COVID-19: a case for inhibiting IL-17?|pdf=|usr=}} | {{tp|p=32358580|t=ä. COVID-19: a case for inhibiting IL-17?|pdf=|usr=}} | ||
| + | {{tp|p=32302707|t=ä. Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?: This paper is dedicated to Sofia Maione born during COVID-19 outbreak |pdf=|usr=}} '''frisch geboren und schon publiziert...''' | ||
Version vom 18. Juni 2020, 11:48 Uhr
32353597 ä. SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy
32358580 ä. COVID-19: a case for inhibiting IL-17?
32302707 ä. Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?: This paper is dedicated to Sofia Maione born during COVID-19 outbreak frisch geboren und schon publiziert...
